Selected research
Industry Growth & Trends
Global Dengue Fever Testing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Dengue Fever Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Dengue Fever Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Dengue Fever Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dengue Fever Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Dengue Fever Testing market include Quest Diagnostics, Certest Biotec, OriGene Technologies, Thermo Fisher, Abnova, Roche Molecular Systems, Abbott Laboratories, InBios International and NovaTec Immundiagnostica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Dengue Fever Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Dengue Fever Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dengue Fever Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dengue Fever Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Dengue Fever Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Dengue Fever Testing Market by Company
Quest Diagnostics
Certest Biotec
OriGene Technologies
Thermo Fisher
Abnova
Roche Molecular Systems
Abbott Laboratories
InBios International
NovaTec Immundiagnostica
Sub.PerkinElmer
Dengue Fever Testing Segment by Type
ELISA-Based Tests
RT-PCR Based Tests
Dengue IgG/IgM Rapid Test
Dengue Fever Testing Segment by Application
Hospitals
Public Health Laboratory
Diagnostic Centers
Others
Dengue Fever Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dengue Fever Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dengue Fever Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dengue Fever Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Dengue Fever Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- ELISA-Based Tests
- RT-PCR Based Tests
- Dengue IgG/IgM Rapid Test
Applications
- Hospitals
- Public Health Laboratory
- Diagnostic Centers
- Others
Companies covered
- Quest Diagnostics
- Certest Biotec
- OriGene Technologies
- Thermo Fisher
- Abnova
- Roche Molecular Systems
- Abbott Laboratories
- InBios International
- NovaTec Immundiagnostica
- Sub.PerkinElmer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Dengue Fever Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Dengue Fever Testing Market Size by Region (2021-2032)
- 1.4.1 Global Dengue Fever Testing Market Size by Region (2021-2026)
- 1.4.2 Global Dengue Fever Testing Market Size by Region (2027-2032)
- 1.5 Key Regions Dengue Fever Testing Market Size (2021-2032)
- 1.5.1 North America Dengue Fever Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Dengue Fever Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Dengue Fever Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Dengue Fever Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Dengue Fever Testing Market Size Growth Rate (2021-2032)
2 Dengue Fever Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 ELISA-Based Tests
- 2.1.2 RT-PCR Based Tests
- 2.1.3 Dengue IgG/IgM Rapid Test
- 2.2 Global Dengue Fever Testing Market Size by Type
- 2.2.1 Global Dengue Fever Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Dengue Fever Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Dengue Fever Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Dengue Fever Testing Market Size by Regions
- 2.3.1 North America Dengue Fever Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Dengue Fever Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Dengue Fever Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Dengue Fever Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Dengue Fever Testing Market Size Breakdown by Type (2021-2026)
3 Dengue Fever Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Public Health Laboratory
- 3.1.3 Diagnostic Centers
- 3.1.4 Others
- 3.2 Global Dengue Fever Testing Market Size by Application
- 3.2.1 Global Dengue Fever Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Dengue Fever Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Dengue Fever Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Dengue Fever Testing Market Size by Regions
- 3.3.1 North America Dengue Fever Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Dengue Fever Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Dengue Fever Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Dengue Fever Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Dengue Fever Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Dengue Fever Testing Industry Trends
- 4.2 Dengue Fever Testing Industry Drivers
- 4.3 Dengue Fever Testing Industry Opportunities and Challenges
- 4.4 Dengue Fever Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Dengue Fever Testing Revenue (2021-2026)
- 5.2 Global Dengue Fever Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Dengue Fever Testing Key Company Headquarters & Area Served
- 5.4 Global Dengue Fever Testing Company, Product Type & Application
- 5.5 Global Dengue Fever Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Dengue Fever Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Dengue Fever Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 Dengue Fever Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Quest Diagnostics
- 6.1.1 Quest Diagnostics Company Information
- 6.1.2 Quest Diagnostics Business Overview
- 6.1.3 Quest Diagnostics Dengue Fever Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Quest Diagnostics Dengue Fever Testing Product Portfolio
- 6.1.5 Quest Diagnostics Recent Developments
- 6.2 Certest Biotec
- 6.2.1 Certest Biotec Company Information
- 6.2.2 Certest Biotec Business Overview
- 6.2.3 Certest Biotec Dengue Fever Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Certest Biotec Dengue Fever Testing Product Portfolio
- 6.2.5 Certest Biotec Recent Developments
- 6.3 OriGene Technologies
- 6.3.1 OriGene Technologies Company Information
- 6.3.2 OriGene Technologies Business Overview
- 6.3.3 OriGene Technologies Dengue Fever Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 OriGene Technologies Dengue Fever Testing Product Portfolio
- 6.3.5 OriGene Technologies Recent Developments
- 6.4 Thermo Fisher
- 6.4.1 Thermo Fisher Company Information
- 6.4.2 Thermo Fisher Business Overview
- 6.4.3 Thermo Fisher Dengue Fever Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Thermo Fisher Dengue Fever Testing Product Portfolio
- 6.4.5 Thermo Fisher Recent Developments
- 6.5 Abnova
- 6.5.1 Abnova Company Information
- 6.5.2 Abnova Business Overview
- 6.5.3 Abnova Dengue Fever Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Abnova Dengue Fever Testing Product Portfolio
- 6.5.5 Abnova Recent Developments
- 6.6 Roche Molecular Systems
- 6.6.1 Roche Molecular Systems Company Information
- 6.6.2 Roche Molecular Systems Business Overview
- 6.6.3 Roche Molecular Systems Dengue Fever Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Roche Molecular Systems Dengue Fever Testing Product Portfolio
- 6.6.5 Roche Molecular Systems Recent Developments
- 6.7 Abbott Laboratories
- 6.7.1 Abbott Laboratories Company Information
- 6.7.2 Abbott Laboratories Business Overview
- 6.7.3 Abbott Laboratories Dengue Fever Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Abbott Laboratories Dengue Fever Testing Product Portfolio
- 6.7.5 Abbott Laboratories Recent Developments
- 6.8 InBios International
- 6.8.1 InBios International Company Information
- 6.8.2 InBios International Business Overview
- 6.8.3 InBios International Dengue Fever Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 InBios International Dengue Fever Testing Product Portfolio
- 6.8.5 InBios International Recent Developments
- 6.9 NovaTec Immundiagnostica
- 6.9.1 NovaTec Immundiagnostica Company Information
- 6.9.2 NovaTec Immundiagnostica Business Overview
- 6.9.3 NovaTec Immundiagnostica Dengue Fever Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 NovaTec Immundiagnostica Dengue Fever Testing Product Portfolio
- 6.9.5 NovaTec Immundiagnostica Recent Developments
- 6.10 Sub.PerkinElmer
- 6.10.1 Sub.PerkinElmer Company Information
- 6.10.2 Sub.PerkinElmer Business Overview
- 6.10.3 Sub.PerkinElmer Dengue Fever Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Sub.PerkinElmer Dengue Fever Testing Product Portfolio
- 6.10.5 Sub.PerkinElmer Recent Developments
7 North America
- 7.1 North America Dengue Fever Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Dengue Fever Testing Market Size by Country (2021-2026)
- 7.3 North America Dengue Fever Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Dengue Fever Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Dengue Fever Testing Market Size by Country (2021-2026)
- 8.3 Europe Dengue Fever Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Dengue Fever Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Dengue Fever Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Dengue Fever Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Dengue Fever Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Dengue Fever Testing Market Size by Country (2021-2026)
- 10.3 South America Dengue Fever Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Dengue Fever Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Dengue Fever Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Dengue Fever Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst